Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: lysosomal acid lipase - Large Scale Biology Corporation

Drug Profile

Research programme: lysosomal acid lipase - Large Scale Biology Corporation

Latest Information Update: 20 Feb 2008

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Cincinnati
  • Developer Large Scale Biology Corporation (CEASED)
  • Class Cardiovascular therapies
  • Mechanism of Action Enzyme replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Atherosclerosis
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Atherosclerosis

Most Recent Events

  • 23 Dec 2005 Large Scale Biology Corporation ceased operations
  • 23 Sep 2005 Large Scale Biology Corporation and Icon Genetics announced the initiation of the commercial phase of their collaborative agreement for an undisclosed product for enzyme replacement therapy
  • 01 Aug 2005 Lysosomal acid lipase has received orphan drug status in the USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top